Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-19

FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lubiprostone from Dr. Reddy's Laboratories Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUBIPROSTONE (lubiprostone)

Snippet

SUPPL AP for LUBIPROSTONE (LUBIPROSTONE)